Literature DB >> 28079375

Docking of Macrocycles: Comparing Rigid and Flexible Docking in Glide.

Hiba Alogheli1, Gustav Olanders1, Wesley Schaal1, Peter Brandt1, Anders Karlén1.   

Abstract

In recent years, there has been an increased interest in using macrocyclic compounds for drug discovery and development. For docking of these commonly large and flexible compounds to be addressed, a screening and a validation set were assembled from the PDB consisting of 16 and 31 macrocycle-containing protein complexes, respectively. The macrocycles were docked in Glide by rigid docking of pregenerated conformational ensembles produced by the macrocycle conformational sampling method (MCS) in Schrödinger Release 2015-3 or by direct Glide flexible docking after performing ring-templating. The two protocols were compared to rigid docking of pregenerated conformational ensembles produced by an exhaustive Monte Carlo multiple minimum (MCMM) conformational search and a shorter MCMM conformational search (MCMM-short). The docking accuracy was evaluated and expressed as the RMSD between the heavy atoms of the ligand as found in the X-ray structure after refinement and the poses obtained by the docking protocols. The median RMSD values for top-scored poses of the screening set were 0.83, 0.80, 0.88, and 0.58 Å for MCMM, MCMM-short, MCS, and Glide flexible docking, respectively. There was no statistically significant difference in the performance between rigid docking of pregenerated conformations produced by the MCS and direct docking using Glide flexible docking. However, the flexible docking protocol was 2-times faster in docking the screening set compared to that of the MCS protocol. In a final study, the new Prime-MCS method was evaluated in Schrödinger Release 2016-3. This method is faster compared that of to MCS; however, the conformations generated were found to be suboptimal for rigid docking. Therefore, on the basis of timing, accuracy, and ease of set up, standard Glide flexible docking with prior ring-templating is recommended over current gold standard protocols using rigid docking of pregenerated conformational ensembles.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28079375     DOI: 10.1021/acs.jcim.6b00443

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  13 in total

1.  Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ring.

Authors:  Adel A Rashad; Kriti Acharya; Ann Haftl; Rachna Aneja; Alexej Dick; Andrew P Holmes; Irwin Chaiken
Journal:  Org Biomol Chem       Date:  2017-09-26       Impact factor: 3.876

2.  Cyclization and Docking Protocol for Cyclic Peptide-Protein Modeling Using HADDOCK2.4.

Authors:  Vicky Charitou; Siri C van Keulen; Alexandre M J J Bonvin
Journal:  J Chem Theory Comput       Date:  2022-06-02       Impact factor: 6.578

3.  Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites.

Authors:  Paris R Watson; Timothy W Craven; Xinting Li; Stephen Rettie; Parisa Hosseinzadeh; Fátima Pardo-Avila; Asim K Bera; Vikram Khipple Mulligan; Peilong Lu; Alexander S Ford; Brian D Weitzner; Lance J Stewart; Adam P Moyer; Maddalena Di Piazza; Joshua G Whalen; Per Jr Greisen; David W Christianson; David Baker
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

4.  Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries.

Authors:  Yosef Masoudi-Sobhanzadeh; Aysan Salemi; Mohammad M Pourseif; Behzad Jafari; Yadollah Omidi; Ali Masoudi-Nejad
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

5.  Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?

Authors:  Vasanthanathan Poongavanam; Emma Danelius; Stefan Peintner; Lilian Alcaraz; Giulia Caron; Maxwell D Cummings; Stanislaw Wlodek; Mate Erdelyi; Paul C D Hawkins; Giuseppe Ermondi; Jan Kihlberg
Journal:  ACS Omega       Date:  2018-09-24

6.  Milk Peptides as Novel Multi-Targeted Therapeutic Candidates for SARS-CoV2.

Authors:  H Pradeep; Umme Najma; H S Aparna
Journal:  Protein J       Date:  2021-04-11       Impact factor: 2.371

7.  Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice.

Authors:  Wei Chen; Fengchun Shui; Cheng Liu; Xinbo Zhou; Wei Li; Zhibing Zheng; Wei Fu; Lili Wang
Journal:  Front Pharmacol       Date:  2017-10-05       Impact factor: 5.810

8.  Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.

Authors:  Dennis M Krüger; Adrian Glas; David Bier; Nicole Pospiech; Kerstin Wallraven; Laura Dietrich; Christian Ottmann; Oliver Koch; Sven Hennig; Tom N Grossmann
Journal:  J Med Chem       Date:  2017-10-27       Impact factor: 7.446

9.  Conformational analysis of macrocycles: comparing general and specialized methods.

Authors:  Gustav Olanders; Hiba Alogheli; Peter Brandt; Anders Karlén
Journal:  J Comput Aided Mol Des       Date:  2020-01-21       Impact factor: 3.686

10.  Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study.

Authors:  Cheng Peng; Yoseph Atilaw; Jinan Wang; Zhijian Xu; Vasanthanathan Poongavanam; Jiye Shi; Jan Kihlberg; Weiliang Zhu; Máté Erdélyi
Journal:  ACS Omega       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.